All Articles

Moving On to New Challenges

Jeff Stewart’s career as a nurse has never lacked variety, colour and challenge. He had worked with MSF in South Sudan, Rwanda and Liberia, with Aboriginal health services in Yalata, …

28 January 2026

Could New Hepatitis B Drug – Bepirovirsen – Offer a Higher Functional Cure Rate?

At the start of January, pharmaceutical company GSK announced positive results from its two phase-III trials for bepirovirsen, a potential first-in-class treatment for chronic hepatitis B. They claim that bepirovirsen …

21 January 2026

‘Shared decision-making’ for childhood vaccines sounds empowering – but it may mean less access for families already stretched thin

Shared decision-making is an approach doctors use when there’s genuinely more than one reasonable choice and the answer depends on what matters most and feels right to the patient.

16 January 2026

Why the Hepatitis B Birth Dose Matters

Hepatitis B vaccination within the first 24 hours has been part of Australia’s National Immunisation Program for 25 years, helping to reduce hepatitis B in the Australian population.

18 December 2025

Curing Hepatitis C Reduces Strain on the Immune System of HIV Patients

Fighting two infections at once puts an extra-heavy burden on the immune system. In Australia for example, a number of older people with haemophilia live with both hepatitis C and …

18 December 2025

Pages of clinicians and researchers statement showing names and logos

Hepatitis Experts Welcome ATAGI Statement on Hepatitis B Birth Dose Vaccination

Australia’s hepatitis experts have welcomed a new statement from the Australian Technical Advisory Group on Immunisation (ATAGI) confirming the importance and safety of administering the hepatitis B vaccine at birth. Responding to …

16 December 2025

Abandoning Hepatitis B Vaccines for Babies is Bad Science and Bad Medicine

Hepatitis Australia, ASHM and the Australian Technical Group on Immunisation (ATAGI) are urging Australians to maintain routine hepatitis B vaccinations for newborns following the alarming news that the advisory panel …

11 December 2025

Community Leaders Share Concerns About Hepatitis B and the Law

Hepatitis B is Australia’s most prevalent blood-borne virus, with nearly 220,000 people estimated to be living with chronic infection. In a recent report called ‘If Hepatitis was 100 People’, Hepatitis …

10 December 2025

Wait! There’s more…

Hepatitis is not often seen as a health issue for children – but as shown in Community News #107, children can be at risk of hepatitis or hepatitis-related health issues …

4 December 2025 | Issue 107

Treating Fibrosis with Henna

Henna is natural dye, orange-red in colour, made from the powdered leaves of Lawsonia inermis and was being used in body art, and as a dye for hair, nails and …

3 December 2025

A Single-Dose Cure for Hep B?

Hepatitis B remains a global public health problem, even in countries like Australia with universal childhood vaccination. For people who have been infected, and who now live with chronic hepatitis B, …

26 November 2025

Tasmania to pilot national hepatitis C awareness campaign

The Australian Government is funding a new hepatitis C awareness campaign to be piloted in Tasmania, as part of national efforts to identify and treat people who may be living with the …

20 November 2025

Spreading the Word about Hepatitis B and D

Adrian Hicks wants to shout out to the world: If you have hepatitis B, don’t ignore it… do something, your life may depend on it! Adrian lives with not one …

20 November 2025

In Our Library: October 2025 Highlights

HepSA Library October acquisition highlights: HBV surveillance, managing hep B, hep D advances, and more…

19 November 2025

UK Shows the Power of Opt-Out Testing

Thousands of Britons have been found to have been living with previously undiagnosed hepatitis and HIV under a new testing system recently introduced in accident and emergency departments by the …

14 November 2025

Understanding Clinical Trials in MASLD

Involvement in a clinical trial may provide access to new treatments and provide participants with a higher level of clinical care, which many people with fatty liver find beneficial.

12 November 2025

Pig-to-Human Liver Transplant Shows Mixed Success

Part of a liver from a genetically engineered pig has been transplanted into a living human recipient, who then survived a further six months before dying from repeated upper gastrointestinal …

5 November 2025

While We Wait for a Hepatitis B Cure – Screen More, Treat More, Treat Earlier

The hepatitis B virus (HBV) is notoriously hard to get rid of. The virus embeds its covalently closed circular DNA (the cccDNA) in the liver, integrating itself into the host …

28 October 2025

My Health Record: BBV results now recorded by default

Recent changes to the processing of pathology reports for My Health Record has elevated the importance of pre-test counselling...

23 October 2025

In Our Library: Life after hepatitis C

Challenges threaten to undermine the individual and public health gains provided by long-awawited hep C cures.

22 October 2025 | Issue 107

On the Ground – Great New Location for Uniting Communities U City NSP

Uniting Communities, its partner agencies and supporters celebrated the opening of a new ground floor space within the U City on Franklin Street.

17 October 2025 | Issue 107

How Machine Learning Can Help Discover Anti-Hepatitis C Drugs

Finding a single novel molecule for drug development can take years. Machine learning can help process billions of molecules in a day, and aid drug discovery against viral illnesses that …

9 October 2025

High Hep C Cure Rate Among NSP Clients

Findings from the Australian Needle and Syringe Program (NSP) Survey 30-year National Data Report shows highly significant reductions in hepatitis C infections and high levels of treatment and cure among …

2 October 2025 | Issue 107

Birth-Dose Vaccination Crucial to Prevention of Chronic Hepatitis B in Children

Hepatitis Australia and ASHM have released a statement reminding all Australians of the importance of hepatitis B vaccinations to protect the health and wellbeing of children. The statement pointed out …

24 September 2025 | Issue 107